The global animal model market size is expected to reach USD 2.63 Billion in 2030 and register a revenue CAGR of 6.2% over the forecast period, according to latest report by Reports and Data.
The global animal model market size is expected to reach USD 2.63 Billion in 2030 and register a revenue CAGR of 6.2% over the forecast period, according to latest report by Reports and Data. Rapid growth in drug discovery and development in pharmaceutical sector, along with increasing use of animal models in basic and applied research, are expected to drive market revenue growth during the forecast period. Increasing demand for mice models for laboratory tests, clinical research, as well as for educational purposes, is expected to support revenue growth of the global animal model market in the near future.
Rising demand for drugs, vaccines, and monoclonal antibodies against emerging diseases has led to increased use of animal models for research & development processes. Mice models are widely used in pharmaceutical as well as biotechnological institutions, due to their small size, average to small span of life and reproductive cycle, and ease of genetic manipulation. The similarity of organ systems of mice with humans also makes them an essential component for drug development and screening, which is increasing demand for mice as an animal model and is expected to drive revenue growth of the market in the near future.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/989
Demand for mice models is rising to avoid risking human lives for clinical trials or drug screening tests, which is expected to support market revenue growth. Additionally, implementation of government regulations in some countries to perform toxicity tests in non-primate organisms during drug development, due to non-primates being a relatively safer option than humans, is leading to increasing demand for animal models. This is expected to drive revenue growth of the global animal model market over the forecast period.
However, there are certain challenges while using animal models that could hamper market revenue growth during the forecast period. Animal welfare organizations in various countries throughout the world have raised concerns against using animals as models for scientific experiments that are more than often lethal or permanently damage the organism’s normal functioning. Moreover, scientific evidence also claims that animals are capable of suffering just as humans do. This has created challenges in keeping up with the regular supply of animal models to its end users, which is expected to restrain revenue growth of the market over the forecast period.
Some Key Highlights in the Report
- Mice segment is expected to account for a larger revenue share over the forecast period. Increasing use of mice models during drug development and discovery is driving revenue growth of this segment. Mice species are essential models in drug development processes, as they are used for testing several types of lead molecules and screening out potential drugs that are safe for use in humans.
- Pharmaceutical segment is expected to account for largest revenue share in the global animal model market between 2022 and 2030. Rising demand for animal models in this sector for research & development to produce medicines, drugs, vaccines, and antibodies is driving revenue growth of this segment. Government regulations in various countries to test drugs in non-primate species is also increasing demand for animal models, which is expected to support revenue growth of this segment over the forecast period.
- North America animal model market is expected to account for largest revenue share in the global market over the forecast period. Rapid growth of pharmaceutical and biotechnology industries in which animal models play an essential part is expected to drive market revenue growth in the region.
- In January 2022, genOway announced a non-exclusive CRISPR/Cas9 license to one of the most important funding institutions of biotechnological research in the UK. This agreement is in line with the company’s strategy to promote the license obtained from Merck back in 2018, and it is expected to help pharmaceutical and biotech industries to obtain expertise on preclinical models from academic institutions in the United Kingdom.
Competitive Landscape:
The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market.
Top Companies Profiled in the Report:
Charles River Laboratories International, Inc., The Jackson Laboratory, Laboratory Corporation of America Holdings, Horizon Discovery Group plc, Trans Genic Inc., genOway, Taconic Biosciences, Inc., Envigo, Inotiv Inc., Janvier Labs, and Ingenious Targeting Laboratory (Ingenious).
To know more about the report, visit @ https://www.reportsanddata.com/report-detail/animal-model-market
Animal Model Market Segmentation:
Species Outlook (Revenue, USD Billion; 2019-2030)
- Rats
- Mice
- Rabbits
- Canines
- Zebrafish
- Mini-pigs
- Sheep
- Goat
- Horse
Application Outlook (Revenue, USD Billion; 2019-2030)
- Drug Discovery and Development
- Basic and Applied Research
- Academic Learning
- Others
Regional Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/989
This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.
Explore Latest Trending Research Reports By Reports and Data’s
IoT in Healthcare Market Size, Share, Trends By Component (Medical Devices, System and Software, Services), By Connectivity Technology (Cellular, Wi-Fi, Near Field Communications, Satellite, Bluetooth, Zigbee), By Application (Telemedicine, Medication Management, Connected Imaging, Others), By End Use, Forecasts To 2027
Nucleic Acid Amplification Testing (NAAT) Market Analysis, By Technique (Target Amplification, Probe Amplification, Signal Amplification) By Application (Infectious Diseases, Cancer, Personalized Medicine, Genetic), Forecasts to 2026
Non-Invasive Brain Trauma Monitoring Devices Market Size, Share and Analysis By Type (Monitoring Devices, Accessories) By Application (Traumatic Brain Injuries, Parkinson, Headache disorders, Epilepsy, Other Applications) By End-User, Forecast to 2027
Medical Document Management Market Analysis, By Product (Solution, Services) By Delivery Mode (On-premises, Web-based, Cloud-based) By Treatment Type By End-Use Forecasts to 2026
Spinal Pumps Market Analysis, By Application (Pain Management, Spasticity management) By End-Use (Clinic, Hospital, ASCs, long term care centers), Forecasts to 2026
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs